Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.54 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.52 |
| ▸ | F2 | P00734 | 1/20 | 0.52 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.52 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.52 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.51 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29470181 | 0.90 | SLC6A2 (0.59) | SLC6A2NTSR2NTSR1NMUR2OPRM1 | |
| SCHEMBL30343609 | 0.88 | OPRM1 (0.56) | SLC6A2NTSR2NTSR1NMUR2OPRM1 | |
| SCHEMBL31483575 | 0.87 | SLC6A2 (0.58) | SLC6A2F2NTSR2NTSR1OPRM1 | |
| SCHEMBL29591691 | 0.87 | SLC6A2 (0.58) | SLC6A2NTSR2NTSR1OPRM1 | |
| SCHEMBL38650937 | 0.86 | NTSR1 (0.58) | SLC6A2NTSR2NTSR1NMUR2 | |
| SCHEMBL30930530 | 0.86 | NPY2R (0.54) | EPHA2NMUR2OPRM1 | |
| SCHEMBL29591862 | 0.85 | SLC6A2 (0.60) | SLC6A2NTSR2NTSR1OPRM1 | |
| SCHEMBL31114351 | 0.84 | SLC6A2 (0.54) | SLC6A2F2OPRM1 | |
| SCHEMBL30753167 | 0.84 | NMUR2 (0.57) | F2CALCRLNMUR2 | |
| SCHEMBL29630445 | 0.84 | SLC6A2 (0.59) | SLC6A2NTSR2NTSR1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220242947-A1 | PROVASOPRESSIN ANTAGONISTS AND USES THEREOF | WOOMERA THERAPEUTICS | 2022-08-04 | — | — | US | disclosed |